Jiangsu Hualan New Pharmaceutical MaterialLtd Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Jiangsu Hualan New Pharmaceutical MaterialLtd has a total shareholder equity of CN¥2.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.5B and CN¥241.6M respectively. Jiangsu Hualan New Pharmaceutical MaterialLtd's EBIT is CN¥34.6M making its interest coverage ratio -0.9. It has cash and short-term investments of CN¥683.6M.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
CN¥0
Schuld
| Rente dekkingsratio | -0.9x |
| Contant | CN¥683.65m |
| Aandelen | CN¥2.23b |
| Totaal verplichtingen | CN¥241.57m |
| Totaal activa | CN¥2.47b |
Recente financiële gezondheidsupdates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: 301093's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥160.1M).
Langlopende schulden: 301093's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥81.5M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 301093 is debt free.
Schuld verminderen: 301093 has no debt compared to 5 years ago when its debt to equity ratio was 41.6%.
Schuldendekking: 301093 has no debt, therefore it does not need to be covered by operating cash flow.
Rentedekking: 301093 has no debt, therefore coverage of interest payments is not a concern.